Kobayashi Pharmaceutical Co., Ltd. (4967.T)
- Previous Close
5,580.00 - Open
5,580.00 - Bid --
- Ask --
- Day's Range
5,502.00 - 5,599.00 - 52 Week Range
4,700.00 - 8,530.00 - Volume
990,600 - Avg. Volume
2,807,757 - Market Cap (intraday)
412.061B - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
20.66 - EPS (TTM)
268.28 - Earnings Date May 8, 2024 - May 13, 2024
- Forward Dividend & Yield 118.00 (2.13%)
- Ex-Dividend Date Jun 27, 2024
- 1y Target Est
8,211.30
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company offers Ammeltz, a topical analgesic; Bluelet Decoral, a toilet bowl cleaner and freshener; Shoshugen, air freshener; Inochi no Haha, a women's health medicine; Eyebon, an eye wash; Sarasaty lingerie soap; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. It also manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, and health foods; and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Further, it engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Additionally, the company engages in sanitary paper products related businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
www.kobayashi.co.jp3,534
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 4967.T
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4967.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4967.T
Valuation Measures
Market Cap
412.06B
Enterprise Value
333.21B
Trailing P/E
20.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.42
Price/Book (mrq)
2.01
Enterprise Value/Revenue
1.92
Enterprise Value/EBITDA
9.90
Financial Highlights
Profitability and Income Statement
Profit Margin
11.73%
Return on Assets (ttm)
6.12%
Return on Equity (ttm)
10.10%
Revenue (ttm)
173.45B
Net Income Avi to Common (ttm)
20.34B
Diluted EPS (ttm)
268.28
Balance Sheet and Cash Flow
Total Cash (mrq)
79.84B
Total Debt/Equity (mrq)
0.48%
Levered Free Cash Flow (ttm)
2.53B
Research Analysis: 4967.T
Company Insights: 4967.T
4967.T does not have Company Insights